Even with ACL coming off heavy for its trial results its valuation is multiples of that of VHL , how VHL can only have a enterprise valuation of a few million is beyond me. Fair value purely on risk/reward compared to other Bio's would value this stock at least 2 to 3 cents per share imo.
Even with ACL coming off heavy for its trial results its...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
